AlphaTON Capital Corp Files 6-K Report
Ticker: ATON · Form: 6-K · Filed: Oct 22, 2025 · CIK: 1095435
Sentiment: neutral
Topics: foreign-private-issuer, sec-filing, corporate-update
TL;DR
AlphaTON Capital Corp (fka Portage Biotech) filed a 6-K, standard foreign issuer report.
AI Summary
AlphaTON Capital Corp, formerly known as Portage Biotech Inc., filed a Form 6-K on October 22, 2025. The company, incorporated in D8 and headquartered in Tortola, British Virgin Islands, operates in the Pharmaceutical Preparations sector. This filing is a report of a foreign private issuer.
Why It Matters
This filing indicates routine reporting for a foreign private issuer, providing transparency on corporate activities and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Players & Entities
- AlphaTON Capital Corp (company) — Filer of the report
- Portage Biotech Inc. (company) — Former name of AlphaTON Capital Corp
- 20251022 (date) — Filing date
- 001-40086 (other) — SEC file number
FAQ
What is the primary purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, filed for the month of October 2025.
What is the current name of the company filing this report?
The current name of the company is AlphaTON Capital Corp.
What were some of the former names of AlphaTON Capital Corp?
AlphaTON Capital Corp was formerly known as Portage Biotech Inc. (since 20130822), Bontan Corp Inc (since 20030421), and Dealcheck Com Inc (since 19990921).
Where is AlphaTON Capital Corp's principal executive office located?
The principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Under which SEC Act is this filing made?
This filing is made under the 1934 Act.
Filing Stats: 242 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2025-10-22 09:00:29
Filing Documents
- f6k_102125.htm (6-K) — 8KB
- 0001171843-25-006582.txt ( ) — 10KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October, 2025 Commission File Number: 001-40086 AlphaTON Capital Corp (Translation of registrant's name into English) Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ X ] Form 40-F [ ] INCORPORATION BY REFERENCE This report on Form 6-K (including any exhibits attached hereto) shall be deemed to be incorporated by reference into the registration statements on Form S-8 (File Nos. 333-275842 and 333-289199) and Form F-3 (File Nos. 333-286961 and 333-290827) of AlphaTON Capital Corp (including any prospectuses forming a part of each such registration subsequently filed or furnished. There were 6,349,197 ordinary shares of AlphaTON Capital Corp outstanding as of October 20, 2025. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 22, 2025 ALPHATON CAPITAL CORP By: /s/ Brittany Kaiser Brittany Kaiser Chief Executive Officer